Allow me to share the futurist modality—ECP with you.

Human body is a conglomeration of complex organs made up of special cells undergoing complex chemical changes in stride to keep body fit. Most suffered and diseased area today is our circulatory system of blood stream with 112, 000 kms of route to cover which carry nutrition to each and every cell and also acts as a garbage man and delivery boy with 60 trillion customers i.e. 17, 000 times the number of people on earth. Even in vital organs nature has provided plenty of collaterals. This transport system undergoes continuous degeneration & regeneration as is evident from the fact that arteries grows erratically even at decaying age of 80 where abnormal arteries supply the cancer mass and take enormous size to grow up to little finger size.

The damage to the intima of arteries may it be due to atheromatous plaque, homocytiene levels, inflammation or trauma cause blockage in the artery. As a result the victim is the vital organ endangering the life of man. Till date, not many solutions to identify the arterial damage and then treatment of the same are at hand either with pharmacy or noninvasive means. Only some success has been achieved in case of heart, where highly invasive procedures are adopted. In recent years, External Counter Pulsation (ECP) has surfaced as a landmark therapy where application in hopeless cardiac cases like MI, CAD, CCF, Cardiogenic shock and post invasive intervention failures / recurrences has shown its good clinical results. Over fluid load in CCF, renal diseases etc have been relieved with ECP due to enhanced blood flow to kidneys. Having worked with ECP on cardiac cases, it is seen that after few hours of treatment a very good ventricular assist pulse is produced thereby decreasing LV systolic effort and finally the heart is put to rest for few hours (which can never happen normally), eventually causing revival of myocardium.

ECP causes sheer stress on circulatory system thereby enhancing arterial elasticity, forced opening of the collaterals and enhanced release of vascular endothelium growth factor like COQ2, Nitric Oxide, Argenin and like. Its anti atherosclerotic action, restoration of vascular endothelial dysfunction, improved homodynamic effects have been clinically proven now.

Apart from cardiac applications, ECP is going to be “the therapy of tomorrow” for angiology related disorders viz: 1.Stroke-Paralysis 2.Cerebral Palsy 3. Ischemic Cerebral Diseases 4.Parkinson’s Disease 5.Renal Ischemia 6.Uremia 7.Diabetes 8.Gangrene 9.Peripheral Vascular Disease 10.Sudden Deafness and Blindness due to vascular origin 11.Sports Fatigue 12. Preventive Cardiology 13.Hepatitis 14.Rheumatoid Arthritis 15.Inter-vertebral Disc Prolapse 16. Avascular Necrosis of bones. 17. Most of the metabolic diseases. The list is too long but all above ailments have been treated with ECP, in different parts of the world, with enormous clinical success. Lot of research is demanded in these Angiology related areas which appears to be a forgotten part of the body yet evidently the most important.

In sum, Angiology requires at par research & attention as like other organs. It is worth it, since the health of all body organs – and hence of human life largely depends on circulatory system.

But it is possible only if right device is selected and therapist behind it applies ECP properly. Lastly, let me not forget to mention that ECP his absolutely natural, harmless, non-invasive, non-surgical, non-pharmaceutical, out patient therapy; now approved by USA (FDA), NHS {Eng}, CE Mark Certification {Europe} and ISO {China}. ECP has also been recognized and supported by Harrison’s and Braunwalds’s apart from other eminent clinical journals like The American Journal of Cardiology, Journal of the American College of Cardiology European Heart Journal, Journal of Investigative Medicine and many more.

EECP - The Angina and Heart Failure Solution

ECP is a proven therapy which has been shown to improve cardiac blood flow and lower the risk of hospitalizations and mortality in patients suffering from persistent angina and heart failure. ECP has been FDA approved for the treatment of chronic angina and heart failure, after massive research and trails ( MUST trial , PEECH trial)

The treatment involves lying down on a special treatment bed and wrapping the legs in special air filled cuffs. The cuffs are sequentially inflated and deflated as per the patient's ECG so that blood is pumped back to the heart and into the coronary arteries. This treatment has been shown to be very effective in reducing anginal and heart failure symptoms in patients suffering from heart disease in several studies conducted around the world. We have seen similar results using this therapy at our institute as well. The External Counter Pulsation (ECP) device is a non-invasive treatment for patients suffering from stable or unstable angina pectoris, acute myocardial infarction and Cardiogenic shock.

Amazingly most of the Indian medical faculty either not aware of this latest development or hesitate to adopt the latest as the therapy is not very common.

450 US academic institutes and independent physicians , Corporate hospitals in US and 13 other countries are using ECP. To name few * Beth Israel Medical Center * The Cleveland Clinic Chain * Columbia University * Harvard Cardiac Research Foundation * JFK Medical Center * Johns Hopkins Medical Center * Mayo Clinic Chain * University of California San Francisco * Yale. In India Escorts Hospital under Dr. Trehan , Asian Heart Institute under Dr. Ramakant Panda Cardiac Surgeon to the President of India are among the first to install the facility apart from 50 other center in India.

I welcome you to join hands in ushering in a new era through a modality that is all set to revolutionize non invasive cardiac and circulatory care.



Dr.Ashok Aggarwal
Director